Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples